• Users Online: 4055
  • Print this page
  • Email this page
Year : 2016  |  Volume : 7  |  Issue : 1  |  Page : 43-45

Treatment of refractory ulcerative necrobiosis lipoidica diabeticorum with oral thalidomide

Department of Dermatology and Venereology, Ashvini Rural Medical College, Solapur, Maharashtra, India

Correspondence Address:
Dr. Swapnil D Shah
441, Shukrawar Peth, Solapur - 413 002, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2229-5178.174328

Rights and Permissions

Ulcerative necrobiosis lipoidica (NL) in diabetic patients is a rare, painful condition. It is a difficult-to-treat condition, impairing quality of life of patients. Although various drugs have been tried, none of them is consistently effective. Biologics in the form of TNF-alpha inhibitors show promising results in the treatment. But because of their high cost we chose thalidomide, which also has TNF-alpha inhibiting properties to successfully treat a long-standing case of ulcerative NL, which was refractory to various treatment modalities.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded251    
    Comments [Add]    
    Cited by others 3    

Recommend this journal